iCAD Brust MRT CAD

SpectraLook with CADvue

The American Cancer Society (ACS) has published updated guidelines for breast cancer screening in high risk women. The ACS now recommends annual breast screening MRI in addition to mammography in women who are at high risk because of a known genetic mutation, who have not been tested but who have a first degree relative with a known mutation, who have a greater than 20%-25% lifetime risk of breast cancer as determined by currently available risk assessment tools, and women who received chest irradiation between the ages of 10 and 30 (1).

In keeping with the ACS recommendations and iCAD's dedication to helping clinicians find the most prevalent cancers earlier, faster and with greater confidence, iCAD introduces MRI image processing, analysis and viewing solutions.

Breast MRI CAD

SpectraLook™ is the next generation in Breast MRI CAD analysis solutions. This technology uses an algorithm based on All Time Points (ATP) which provides enhanced diagnostic information and improves workflow efficiency. ATP technology allows SpectraLook to automatically perform image processing and analysis saving time by eliminating the need for clinicians or technologists to perform some of these tasks. ATP analysis is based on an advanced pharmacokinetic model that creates colorized images and calculates numerical values of key physiological parameters allowing the user to discern the different biological processes taking place in malignant versus benign lesions. These key physiological markers can aid in the analysis of large MR data sets.

MRI Image Review, Analysis and Reporting

CADvue™ is a robust image review and analysis software solution that provides maximum functionality, facilitating the analysis of All Time Point (ATP) colorized images and quantitative data. CADvue allows the user to create standard and customized reports that enable the user to communicate time-sensitive breast MR study results to referring physicians. The reports provide detailed and comprehensive information that is critical to the identification and analysis of abnormalities. 3D colorized images within the report assist clinicians to effectively communicate options to their patients. The CADvue workstation maximizes review and reporting functionality with customizable analysis tools and fully integrated BI-RADS® reports.

(1) Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007; 57:75-89.